Renaissance Capital logo

XBIT News

US IPO Weekly Recap: 7 IPOs see Etsy vault 70%, proving vintage is in vogue

Etsy exploded 88% out of the gate, giving it the best first-day return for a tech IPO in over a year. Cancer immunotherapy biotech Aduro Biotech flew up 147%, the year's third IPO to more than double on day one. This past week was the second largest of 2015...read more

Colorectal cancer biotech Xbiotech prices $76 million IPO at $19 midpoint

Xbiotech, which is developing antibodies for colorectal cancer and various other conditions, raised $76 million by offering 4 million shares at $19, within the range of $18 to $20.  The IPO was being marketed by WR Hambrecht on a "best efforts"...read more

Week ahead: Crafts, cancer cures and cash flow in a week with 7 IPOs including Party City

As many as seven IPOs could price this week, and four have a proposed market cap over $1 billion. So far, only eight companies that large have gone public this year, or 22% of all...read more

Anitbody biotech Xbiotech sets terms for $76 million IPO

Xbiotech, which is developing antibodies for colorectal cancer and various other conditions, announced terms for its IPO on Tuesday. The IPO is being marketed by WR Hambrecht on a "best efforts" basis.  The Austin, TX-based company plans to raise $76...read more